.

Pharmaceutical Business Intelligence

  • Formulary management
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Bumetanide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for bumetanide?

Bumetanide is the generic ingredient in two branded drugs marketed by Sandoz, Teva Parenteral, Ivax Sub Teva Pharms, Validus Pharms Inc, Hospira, Amphastar Pharms Inc, and West-ward Pharms Int, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for bumetanide. Nineteen suppliers are listed for this compound.

Summary for Generic Name: bumetanide

Tradenames:2
Patents:1
Applicants:7
NDAs:9
Drug Master File Entries: see list5
Suppliers / Packagers: see list19
Bulk Api Vendors: see list75
Clinical Trials: see list7
Patent Applications: see list5,588
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:bumetanide at DailyMed

Pharmacology for Ingredient: bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
BUMETANIDE
bumetanide
TABLET;ORAL074225-002Apr 24, 1995RXNoNo► Subscribe► Subscribe
Sandoz
BUMETANIDE
bumetanide
TABLET;ORAL074700-003Nov 21, 1996RXNoYes► Subscribe► Subscribe
Sandoz
BUMETANIDE
bumetanide
TABLET;ORAL074700-002Nov 21, 1996RXNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
BUMETANIDE
bumetanide
TABLET;ORAL074225-001Apr 24, 1995RXNoNo► Subscribe► Subscribe
Validus Pharms Inc
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 1983RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms Inc
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 19833,634,583► Subscribe
Validus Pharms Inc
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 19853,800,534► Subscribe
Validus Pharms Inc
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 19833,806,534► Subscribe
Validus Pharms Inc
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 19833,634,583► Subscribe
Validus Pharms Inc
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 19833,806,534► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc